Emerging evidence on the role of soy in reducing prostate cancer risk

Research output: Contribution to journalReview articlepeer-review

Abstract

Soyfoods are a unique dietary source of isoflavones, which have both hormonal and non-hormonal effects relevant to prostate cancer prevention. In vitro, the main soybean isoflavone, genistein, inhibits prostate cancer cell growth; in animals, most but not all studies show isoflavone-rich soy protein and isolated isoflavones inhibit prostate tumor development. Currently, although only limited epidemiologic data indicate soy intake reduces prostate cancer risk, results from a pilot intervention trial suggest isoflavones may be beneficial to prostate cancer patients. For several reasons, men concerned about their prostate health may consider incorporating soy into their diet. © 2003 International Life Sciences Institute.
Original languageEnglish
Pages (from-to)117-131
Number of pages15
JournalNutrition Reviews
Volume61
Issue number4
DOIs
StatePublished - Apr 1 2003

ASJC Scopus Subject Areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Keywords

  • Cancer
  • Genistein
  • Isoflavones
  • Prostate
  • Review
  • Soy
  • Isoflavones/therapeutic use
  • Humans
  • Middle Aged
  • Risk Factors
  • Rats
  • Male
  • Glycine max
  • Prostatic Neoplasms/etiology
  • Animals
  • Aged
  • Mice
  • In Vitro Techniques

Cite this